Skip to main content
logo
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
14.59
-0.20 (-1.35%)
At close: Sep 4, 2026, 4:00 PM EDT
13.21
-1.38 (-9.46%)
After-hours: Sep 4, 2026, 7:53 PM EDT

Silence Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-59.95-88.61-45.31-54.23-50.33-53.36
Depreciation & Amortization
0.480.560.590.620.60.58
Stock-Based Compensation
6.28.0716.3116.2712.6911.69
Other Operating Activities
-3.297.55-6.213.12-0.6-2.29
Change in Accounts Receivable
0.091.02-0.90.39-0.7237.21
Change in Accounts Payable
-1.44-4.080.5-0.472.023.26
Change in Unearned Revenue
-0.52-0.33-28.79-10.32-5.4411.33
Change in Other Net Operating Assets
16.1613.55-3.83-4.84-15.260.8
Operating Cash Flow
-42.26-62.27-67.64-49.46-57.049.22
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0-0.06-0.21-0.06-0.17-1.78
Sale (Purchase) of Intangibles
-----0.37-0.03
Investment in Securities
72.89-47.94-21.7619.35-19.9513.54
Other Investing Activities
-----0.01
Investing Cash Flow
72.89-47.99-21.9719.29-20.511.75

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------0.29
Net Debt Issued (Repaid)
------0.29
Issuance of Common Stock
00.02142.0931.9452.5841.87
Financing Cash Flow
00.02142.0931.9452.5841.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.320.20.060.75-8.12-0.14
Net Cash Flow
30.32-110.0552.542.52-33.0862.41

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-42.27-62.33-67.85-49.52-57.227.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-6872.52%-11149.55%-156.85%-156.49%-264.22%44.26%
Free Cash Flow Per Share
-0.90-1.32-1.47-1.33-1.780.25
Levered Free Cash Flow
-23.57-39.55-25.37-23.31-26.84-6.72
Unlevered Free Cash Flow
-23.57-39.55-25.37-23.31-26.84-6.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.30.640.430.8--
Change in Working Capital
14.2910.16-33.02-15.24-19.452.6
SEC Filings: 10-K · 10-Q